-transparent.png){kind=logo}
Staphylococcus aureus is a very important pathogen in humans about 20% of all bacterial infections are caused by S. aureus. Because the staphylococcal sensitivity patterns have changed, the aim of this study was to investigate the current susceptibility of the S. aureus strains to 9 antibiotics: penicillin (P), amoxacillin/clavulanic acid (AMC), erythromycin (E), cortimoxazole (SXT), tetracycline (T), chloramphenicol (C), mupirocin (MUP), gentamicin (Ge) and vancomycin (Va). Susceptibility testing was performed by disc diffusion technique, by the procedure outlined by the National Committe for Clinical Laboratory Standards (NCCLS). Susceptibility to methicillin was determined using 5 micrograms methicillin disks. beta-lactamase production in the penicillin-resistant strains was detected with nitrocefin impregnated disk (Cefinase, BBL Microbiology system). The microbiological characteristics of the samples: 338 of the isolates were derived, from noses and the throats 382--from surgical wound secretions. The analysis of the results showed that most S. aureus strains (82.8%) are penicillin resistant and beta-lactamase producing 13.5% of all strains were methicillin-resistant. 16.5%--were erythromycin resistant; 3.2%--were cotrimoxazole resistant; 51.4%--were mupirocin resistant; 20.6%--were gentamicin resistant. All of the strains were vancomycin sensitive.
E Kruszyńska, and
M Białek, and
G Janicka, and
R Bugalski, and
E Belzyt, and
H Czajkowski, and
K Hareńska, and
D Wojciechowska
March 1973,
Paediatrica Indonesiana,
E Kruszyńska, and
M Białek, and
G Janicka, and
R Bugalski, and
E Belzyt, and
H Czajkowski, and
K Hareńska, and
D Wojciechowska
January 1992,
Medycyna doswiadczalna i mikrobiologia,
E Kruszyńska, and
M Białek, and
G Janicka, and
R Bugalski, and
E Belzyt, and
H Czajkowski, and
K Hareńska, and
D Wojciechowska
September 2004,
The Journal of antimicrobial chemotherapy,
E Kruszyńska, and
M Białek, and
G Janicka, and
R Bugalski, and
E Belzyt, and
H Czajkowski, and
K Hareńska, and
D Wojciechowska
June 1976,
Antimicrobial agents and chemotherapy,
E Kruszyńska, and
M Białek, and
G Janicka, and
R Bugalski, and
E Belzyt, and
H Czajkowski, and
K Hareńska, and
D Wojciechowska
January 2008,
Przeglad lekarski,
E Kruszyńska, and
M Białek, and
G Janicka, and
R Bugalski, and
E Belzyt, and
H Czajkowski, and
K Hareńska, and
D Wojciechowska
November 2000,
The Pediatric infectious disease journal,
E Kruszyńska, and
M Białek, and
G Janicka, and
R Bugalski, and
E Belzyt, and
H Czajkowski, and
K Hareńska, and
D Wojciechowska
April 1954,
Prensa medica argentina,
E Kruszyńska, and
M Białek, and
G Janicka, and
R Bugalski, and
E Belzyt, and
H Czajkowski, and
K Hareńska, and
D Wojciechowska
December 1959,
Antibiotics & chemotherapy (Northfield, Ill.),
E Kruszyńska, and
M Białek, and
G Janicka, and
R Bugalski, and
E Belzyt, and
H Czajkowski, and
K Hareńska, and
D Wojciechowska
August 1970,
Polski tygodnik lekarski (Warsaw, Poland : 1960),
E Kruszyńska, and
M Białek, and
G Janicka, and
R Bugalski, and
E Belzyt, and
H Czajkowski, and
K Hareńska, and
D Wojciechowska
April 1981,
Antibiotiki,
